Media Coverage header image

Media Coverage

Advanced Search
  • 02042019
    Electrical Contractor

    A 2017 survey conducted by the National Safety Council found employee use of prescription drugs on the job had affected a majority of employers. The most significant effect was absenteeism or missed work (reported by 39 percent of respondents) followed by impaired or decreased job performance (reported by 29 percent) and safety concerns, such as injuries or near misses (reported by 15 percent). However, a more recent report from December 2018 is cause for even more concern—the use of non-prescription drugs in the workplace.

  • 02012019
    Electrical Contractor Online

    A 2017 survey conducted by the National Safety Council found employee use of prescription drugs on the job had affected a majority of employers. The most significant effect was absenteeism or missed work (reported by 39 percent of respondents) followed by impaired or decreased job performance (reported by 29 percent) and safety concerns, such as injuries or near misses (reported by 15 percent). However, a more recent report from December 2018 is cause for even more concern—the use of non-prescription drugs in the workplace. A new report published by Quest Diagnostics notes such drug use among the U.S. workforce is increasing at an alarming rate.

  • 02012019
    marketscreener.com

    Data detailed on Oncology - Chronic Lymphocytic Leukemia have been presented. According to news reporting originating from Marlborough, Massachusetts, by NewsRx correspondents, research stated, "The prognostic role of cytogenetic analysis is well-established in B-cell chronic lymphocytic leukemia (CLL). Approximately 80% of patients have a cytogenetic aberration." Our news editors obtained a quote from the research from Quest Diagnostics, "Interphase FISH panels have been the gold standard for cytogenetic evaluation, but conventional cytogenetics allows detection of additional abnormalities, including translocations, complex karyotypes and multiple clones.

  • 02012019
    MyHeadlinez Online

    In 2018, five major healthcare companies - Humana, MultiPlan, Optum, Quest Diagnostics, and UnitedHealthcare - formed the Synaptic Health Alliance (the `Alliance`) to explore how blockchain technology could resolve current healthcare issues.

  • 01312019
    Delta County

    Delta County residents will want to mark their 2019 calendars for Delta County community-wide health fairs which include early blood draw events in early February or health fairs in mid-March in Paonia, Cedaredge and Delta. Delta County Memorial Hospital Volunteers and Lions clubs in Delta, Cedaredge and Paonia will be partnering in the annual community health fair events again. There will be no price increases on the cost of any of the blood work in 2019. Quest Diagnostics will be providing the health screen results in a booklet format to help health fair participants easily understand the meaning of each of the health screen results.

  • 01312019
    The Fix

    Marijuana is the substance most often detected in workplace drug screenings, according to a new study. More and more employees are testing positive for drugs in workplace screenings, an increase that is concerning for some employers and safety specialists. According to a study by Quest Diagnostics, positive drugs tests have increased significantly in a two-year period between 2015 and 2017.

  • 01242019
    Yahoo Finance

    The idea of sunshine in a bottle vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. According to recent CDC statistics, approximately 45% of middle-aged women and 38% of middle-aged men report taking a vitamin D supplement, and hundreds of thousands of Americans get tested for vitamin D deficiency each year. VITAL was supported by the NIH. Manson reports she received grants from the NIH, nonfinancial support from BASF, Pharmavite, Pronova BioPharma and Quest Diagnostics during the conduct of the VITAL study. Ng has received research funding from Pharmavite. Bernal-Mizrachi, Clarke and Michos report no relevant financial disclosures.

  • 01242019
    CoinDesk

    IBM is collaborating with a group of major players in the healthcare space to improve the way sensitive data is shared and make health claims and transactions more efficient – all in the form of a “blockchain-based ecosystem.” In such a busy space it’s not surprising IBM is faced with some consortia competition. For example, in April of last year, Humana and United Health Group, two of the largest health insurers, teamed up on a blockchain pilot with data providers Quest Diagnostics, Multiplan and Optum.

  • 01222019
    PR Newswire

    Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year. The annual survey designated Quest Diagnostics as one of only five companies to attain Most Admired status in the "Health Care: Pharmacy and Other Services" industry category.

  • 01222019
    KQCW-TV Online

    Good Leads has experience in generating technology sales leads with providers such as Quest Diagnostics, Samsung Neurologica , Fuji Medical, Statlife and Quality Interactions and regularly attends HIMSS and RSNA conferences in support of their IT healthcare and radiology focused customers.

  • 01212019
    CAP Today

    Quest Diagnostics and Oxford Immunotec announced that Quest has completed its acquisition of the U.S. laboratory services business of Oxford Immunotec; the T-Spot.TB tuberculosis and the Accutix tick-borne disease testing services are now part of Quest’s portfolio of infectious disease testing services.

  • 01202019
    Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference
    PR Newswire

    Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco. Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, January 8, 2019 at 7:30 p.m. Eastern Time. Mr. Rusckowski and Mr. Guinan also will participate in a Q&A session moderated by the host analyst.

  • 01182019
    Finance

    The Centers for Disease Control and Prevention (CDC) reported that more than 70,000 people in the United States died of drug overdoses in 2017. That devastating number broke records as the highest number for any single year in our country’s history and contributed to a decrease in life expectancy. Today drug overdoses rank as the leading cause of death for adults under age 55. DownloadQuest Diagnostics white paper about how the opioid crisis affects the workplace.

  • 01182019
    360Dx

    UBS initiated coverage of Quest Diagnostics and Laboratory Corporation of America on Thursday with a Neutral and Buy rating, respectively. In a report, analyst Kevin Caliendo put a a 12-month price target in Quest's shares of $90 and wrote that while he believes Quest could take market share from LabCorp and other competing reference labs, his analysis of Quest's long-term strategic partnership with UnitedHealthcare, announced in May, "suggests less switching to Quest than is expected."

  • 01162019
    Becker's Hospital Review Online

    A recent press release by Quest Diagnostics released new research showing that majority of adults don't know their vital health information, but would like to be able to access their health information online.

  • 01162019
    Workers Compensation

    The rate of positive drug tests rose by double digits in five of 16 major U.S. workforce industry sectors from 2015 to 2017, according to a recent analysis by lab services provider Quest Diagnostics.

  • 01152019
    PatientEngagementHIT.com

    Patient health literacy and knowledge about their own medical information leaves a lot to be desired, leading to calls for better patient education about patient portal and data access, according to a survey conducted by Kelton Global on behalf of Quest Diagnostics.

  • 01152019
    Safety+Health Online

    The rate of positive drug tests rose by double digits in five of 16 major U.S. workforce industry sectors from 2015 to 2017, according to a recent analysis by lab services provider Quest Diagnostics. An examination of data from more than 10 million urine drug tests conducted over the three-year period showed that transportation and warehousing had the largest increase, at 21.4 percent, followed by other services except public administration (15.4 percent), finance and insurance (13), retail trade (12.8), and wholesale trade (11.8).

  • 01112019
    360Dx

    With trends in drug misuse shifting, Quest Diagnostics is using data mining to help clinicians stay on top of the problem. Quest annually mines and analyzes data from millions of drug tests performed at its laboratories across the country. Last fall, the company released its annual Health Trends, Drug Misuse in America 2018 report, based on 3.9 million de-identified, aggregated lab tests conducted at the Quest laboratories between 2011 and 2017. The mining exercise, and the resulting annual report, are intended to serve as a guide for the clinicians it serves, and for its own laboratories looking to better prepare to meet drug testing needs.

  • 01102019
    Penn State News

    Beginning Jan. 1, 2019, employees and their families who have enrolled with Penn State health benefits will pay the least amount of coinsurance (10 percent), after their deductible, for lab services by using Quest Diagnostics or LabCorp.

  • 01082019
    Care2

    Doctors and patients alike need to look at the numbers associated with their hormone levels. The different lab companies that run the blood tests intended to check your hormone levels, such as LabCorp or Quest Diagnostics, have differing ranges for normal, and those may be lowered every few years.

  • 01082019
    FOX Business Network

    Quest Diagnostics CEO Steve Rusckowski on where the opportunities for growth are for the laboratory-services company, the growth of the health-care sector and efforts to reduce health-care spending in America.

  • 01082019
    Verily

    Before you take a vitamin D supplement, you need to get your vitamin D levels checked. This can be done by your doctor, or you can even have it done very inexpensively through a lab such as LabCorp or Quest Labs.

  • 01072019
    Becker's Hospital Review Online

    Tom Romeo, general manager of healthcare IT and Quanum Solutions at Quest Diagnostics, recommended hiring the right staff and utilizing their strengths appropriately.

  • 01052019
    Civilized

    With more and more states legalizing marijuana, you'll often see headlines about how many workers in America are using cannabis. But when you dig into the numbers, it really isn't worth talking about. It should also be noted that all these statistics come from one drug testing lab called Quest Diagnostics. And while Quest Diagnostics is the largest testing lab in the United States, it's not the only one.

Show 5102550100 per page